Kingswood-Backed $3.65 Buyout to Delist Quipt Home Medical
By ATTN Desk · Editorial oversight: Sean Han
Introduction
QUIPT HOME MEDICAL CORP (ticker: QIPT), listed on the Nasdaq Capital Market, provides in-home clinical respiratory care and chronic disease management across the United States. As of December 15, 2025, its share price was $3.54, reflecting a 35.63% increase on trading volume of 1,209,333 shares.
| Metric | Value |
|---|---|
| Share Price (12/15/2025) | $3.54 |
| Daily Change | +35.63% |
| Volume | 1,209,333 |
| Exchange | Nasdaq (NAS) |
| Ticker | QIPT |
Corporate Structure and Workforce
Quipt operates a network of in-home care locations, with three sites in Corinth, Ripley, and New Albany, Mississippi. The company offers services nationwide through its field staff. While total headcount is not publicly disclosed, the company provides benefits for full-time employees working 30 or more hours per week. Benefits include:
- Medical, dental, and vision plans
- Flexible Spending and Health Savings Accounts
- 401(k) retirement plan
- Short-term disability and paid time off
- Mileage reimbursement and travel expense programs
- Employee discount programs
Current recruitment efforts include positions such as regional sales directors, respiratory therapists, and assistive technology professionals.
Home healthcare by Dominik Lange
Developments and News
On December 14, 2025, Quipt Home Medical Corp. entered into an agreement with 1567208 B.C. LTD and REM Aggregator, LLC, with backing from Kingswood Capital Management, LP, to acquire all outstanding common shares at $3.65 per share. The board of directors concluded that this consideration is fair for shareholders. Key dates and filings include:
- December 14, 2025: Signing of the arrangement agreement
- December 15, 2025: Filing of definitive proxy materials (DEFA14A) and Current Report on Form 8-K
- Shareholder vote required by at least 66⅔% approval under British Columbia’s Business Corporations Act
- Upon completion, Quipt’s listings on Nasdaq and the Toronto Stock Exchange will be terminated.
Financial and Strategic Analysis
Quipt reported trailing twelve-month revenue of $238.4 million and a net loss of $10.1 million, with a diluted EPS of ‑$0.34. As per its most recent balance sheet, cash totaled $11.3 million, and the debt-to-equity ratio was 90.7%. Key financial multiples include a price/sales ratio of 0.43 and enterprise value/EBITDA of 3.87.
Strategically, Quipt focuses on technology-enabled respiratory solutions for patients with cardio-pulmonary diseases, sleep disorders, and mobility challenges. The company's model integrates equipment rental, in-home monitoring, and disease management, which is aimed at meeting evolving reimbursement and regulatory environments. Expansion into broader chronic disease management aligns with the goal of diversifying service offerings.
Market Position and Industry Context
The home medical equipment sector is influenced by regulatory oversight, reimbursement rates from payers, and supply chain stability. Quipt’s beta of 0.50 indicates lower volatility compared to the overall market. Its 52-week trading range of $1.90 to $4.75 places the current share price near the upper quartile of this range. Competitive factors include national providers of durable medical equipment and specialized respiratory care firms. An aging population and rising chronic disease prevalence drive long-term demand, while policy shifts related to healthcare coverage may affect future growth trajectories.
tl;dr
On December 14, 2025, Quipt Home Medical Corp. agreed to be acquired at $3.65 per share by entities backed by Kingswood Capital Management. Definitive proxy materials were filed on December 15, 2025, and shareholder approval of at least 66⅔% is required. The transaction will remove QIPT from Nasdaq and TSX listings. With trailing revenue of $238.4 million and a net loss of $10.1 million, the company is preparing for an exit pending shareholder vote.